Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-000174
Filing Date
2025-01-07
Accepted
2025-01-07 16:18:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 6649
  Complete submission text file 0001950047-25-000174.txt   8188
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Subject) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37686 | Film No.: 25515087
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE CAMANA BAY, GRAND CAYMAN E9 KY1-1108
Business Address
Wang Xiaodong (Reporting) CIK: 0001662982 (see all company filings)

Type: 144